Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism – an in vitro study-Reference-Cited by-同舟云学术

Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism – an in vitro study

Published:2009-09 Issue:5 Volume:61 Page:851-858
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Wójcikowski Jacek,Daniel Władysława A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference44 articles.

1. The AGNP TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry;Baumann;Pharmacopsychiatry,2004

2. Sympathomimetic effects of paraxanthine and caffeine in humans;Benowitz;Clin Pharmacol Ther,1995

3. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes;Berthou;Drug Metab Dispos,1991

4. Fluvoxamine is a potent inhibitor of cytochrome P4501A2;Brøsen;Biochem Pharmacol,1993

5. Clinically significant pharmacokinetic interactions between dietary caffeine and medications;Carrillo;Clin Pharmacokinet,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of a hypoxia-immune-related microenvironment gene signature and prediction model for hepatitis C-induced early-stage fibrosis;Journal of Translational Medicine;2024-01-29

2. A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment;Biomolecules;2024-01-12

3. Exploration of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Hepatitis C-induced Early-stage Fibrosis;2023-09-08

4. CYP1A inhibitors: Recent progress, current challenges, and future perspectives;Medicinal Research Reviews;2023-06-19

5. Sex-dependent dynamics of metabolism in primary mouse hepatocytes;Archives of Toxicology;2021-07-09